Clinical trial · Observational
Exploring Biological Linkage Between Circadian Disruption and Cancer Progression
A Prospective Study of Exploring Possible Biological Linkage Between Circadian Disruption and Cancer Progression
NCT02011815CI-TRIAL-00040779completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to explore the possible association between the circadian disruption and cancer progression.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Breast cancer
- description
- Diagnosed breast cancer patients who are getting chemotherapy for the first time.
Primary outcomes (1)
- measure
- Progression-free survival
- timeFrame
- 3 years (and more) after recruitment
- description
- The data progression-free survival will be done by reviewing patients' medical record.
Secondary outcomes (16)
- measure
- Circadian disruption
- timeFrame
- Baseline, after 1 month, after 6 month, after 12 month
- description
- Morningness-Eveningness Questionnaire and Munich Chronotype Questionnaire will be used during assessment.
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Age: 18-70 * Breast cancer patients who are getting chemotherapy for the first time in life * Patients are either having stage 4 cancer or starting neoadjuvant chemotherapy. * Patient have signed on the informed consent, and well understood the objective and procedure of this study Exclusion Criteria: * Patients already have received chemotherapy * Patient had another cancer (except thyroid cancer) within 5 years * Patient with severe medical condition * Patient had taken psychiatric medication more than 1 month in life * Patient worked the night shift for more than 1 month in 6 months
References
Publications (0)
Data not yet available
No reference posted for this study.